戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 e host community was via introduction of the asymptomatic carrier.
2 y and isolated the resistant strain from one asymptomatic carrier.
3 an be accurately detected in symptomatic and asymptomatic carriers.
4 reby contribute to disease dissemination via asymptomatic carriers.
5 ive risks of developing cancer for currently asymptomatic carriers.
6 ll leukemia/lymphoma (ATLL) samples, but not asymptomatic carriers.
7 le at the time of admission, 18 of whom were asymptomatic carriers.
8 lonize the nasopharynges and oropharynges of asymptomatic carriers.
9 n enzyme XbaI, which is useful for detecting asymptomatic carriers.
10  not in several serum-sensitive strains from asymptomatic carriers.
11 erse set of strains in infected patients and asymptomatic carriers.
12 aria cases but be broadened to households of asymptomatic carriers.
13 s propagation by visitors to their house and asymptomatic carriers.
14  of 20/25 Snellen), whereas the other 3 were asymptomatic carriers.
15  toxins and stool IL-1beta in CDI but not in asymptomatic carriers.
16 decision-making regarding preemptive HSCT in asymptomatic carriers.
17  ranging from classical and atypical ADLD to asymptomatic carriers.
18 omprising 620 affected individuals and 4,948 asymptomatic carriers.
19 pulation and all tree populations except for asymptomatic carriers.
20 ng 88 clinically affected individuals and 37 asymptomatic carriers.
21 and causes subclinical cardiac remodeling in asymptomatic carriers.
22  males and presenting a higher proportion of asymptomatic carriers.
23  possibility of transmission of the virus by asymptomatic carriers.
24 of oral cholera vaccine on transmission from asymptomatic carriers.
25 diverse set strains in infected patients and asymptomatic carriers.
26 e important for survival of the parasites in asymptomatic carriers.
27 d pathogen and some S. Typhi patients become asymptomatic carriers.
28 ctions and to decolonize individuals who are asymptomatic carriers.
29  this selection is significantly stronger in asymptomatic carriers.
30 0.84) was significantly greater than that of asymptomatic carriers (3.44 +/- 0.80).
31 athy/tropical spastic paraparesis than in 29 asymptomatic carriers (80% vs 20%; P = .03), and median
32 I-infected individuals with ATL, TSP/HAM, or asymptomatic carriers (AC) for FHIT loss and expression.
33 nfection do not differentiate between HTLV-I asymptomatic carriers (ACs) and ATL and HAM/TSP patients
34 ores were measured in 18 HAM/TSP patients, 4 asymptomatic carriers (ACs) of HTLV-1, 18 MS patients, a
35 tients with familial Alzheimer's disease, 18 asymptomatic carriers and 21 non-carrier controls underw
36           Manifestations of COVID-19 include asymptomatic carriers and fulminant disease characterize
37                    Group comparisons between asymptomatic carriers and healthy controls on standard n
38                     CD8(+) T cells of HTLV-I asymptomatic carriers and healthy donors did not.
39 number of expanded clones were noted between asymptomatic carriers and in patients with HAM/TSP and t
40                                    Moreover, asymptomatic carriers and limited data and surveillance
41 ger number of unique insertion sites than in asymptomatic carriers and not, as previously thought, fr
42              Among 324 strains isolated from asymptomatic carriers and patients from Israel, Europe,
43  genetic relationships between isolates from asymptomatic carriers and patients with HA C. difficile
44 to the predominant PFGE clones isolated from asymptomatic carriers and patients with invasive infecti
45 o did not meet Alzheimer's disease criteria (asymptomatic carriers) and 30 healthy relatives (non-car
46 cognitively normal mutation non-carriers, 20 asymptomatic carriers, and 15 symptomatic mutation carri
47  carriers (72.2% behavioral variant FTD), 83 asymptomatic carriers, and 249 controls (age range = 18-
48  mild cognitive impairment or mild dementia, asymptomatic carriers, and asymptomatic non-carriers.
49 ildren with severe or uncomplicated malaria, asymptomatic carriers, and healthy control subjects who
50 lls producing IFN-gamma in HAM/TSP patients, asymptomatic carriers, and healthy controls were, on ave
51 nsfusion recipients after seroconversion, in asymptomatic carriers, and in ATL and HAM/TSP patients.
52 eight HAM/TSP patients, nine HTLV-I-infected asymptomatic carriers, and seven healthy controls by flo
53                                        Among asymptomatic carriers, antibiotic exposure was not signi
54  transmission from symptomatic CDI patients, asymptomatic carriers appear to have played an important
55                                              Asymptomatic carriers are an active reservoir of C. diff
56 e diagnostic for ultrasensitive detection of asymptomatic carriers as well as a rapid point-of-care c
57 CDI diarrhea (NCD; diarrhea, NAAT negative), asymptomatic carriers (ASC; no diarrhea, NAAT positive)
58  carriers and in 4.6% of patients exposed to asymptomatic carriers at the ward level (odds ratio for
59                                              Asymptomatic carriers cause 76% (95% CI, 59-87%) fewer c
60                                              Asymptomatic carriers cause 76% (95% confidence interval
61              To improve the understanding of asymptomatic carriers' contribution to C. difficile spre
62                                              Asymptomatic carriers differed from controls only in the
63 rataxin concentrations towards those seen in asymptomatic carriers during 8 weeks of daily dosing.
64 s, which could miss a significant portion of asymptomatic carriers during the window period.
65 es may be a steady increase in the number of asymptomatic carriers entering hospitals.
66 model for infectious diseases transmitted by asymptomatic carriers finding, that if harmless and path
67         After colonization, those who became asymptomatic carriers had significantly greater increase
68 ith reduced nigrostriatal dopamine, whereas, asymptomatic carriers have increased dopamine turnover a
69 , making detection of the S. suis species in asymptomatic carrier herds of little practical value in
70  parasitological methods or to the number of asymptomatic carriers in areas of endemicity.
71  pneumococcal strain variability among young asymptomatic carriers in Chile, we used serotyping, anti
72 ion carriers and correlates with the rate of asymptomatic carriers in different populations.
73  transmission in specific locations, whereas asymptomatic carriers (including individuals in their pr
74 (pathogenic isolates 649, 2336, and 8025 and asymptomatic carrier isolates 127P and 129Pt) induce apo
75                  Recent studies suggest that asymptomatic carriers may be an important reservoir of C
76  a PLP probe in five patients and their four asymptomatic carrier mothers.
77          In addition, 4 individuals who were asymptomatic carriers of a disease-causing mutation were
78                     Based on these findings, asymptomatic carriers of a LHON mtDNA mutation should be
79 center for neurodegenerative disorders in 17 asymptomatic carriers of aGRN+ and 14 healthy controls.
80 e earliest detectable brain abnormalities in asymptomatic carriers of ALS-causing gene mutations.
81 nditions (n=12), healthy controls (n=25) and asymptomatic carriers of ALS-causing genetic mutations (
82                                              Asymptomatic carriers of antimicrobial-resistant organis
83 cilitates detection of an auditory target in asymptomatic carriers of Apolipoprotein E4 (APOE4), the
84                                              Asymptomatic carriers of C difficile can spread their in
85 ultures provide an accurate method to detect asymptomatic carriers of C. difficile.
86 ctal versus rectal cultures for detection of asymptomatic carriers of Clostridium difficile were 95%,
87 ot empirically accessible, as in the case of asymptomatic carriers of coronavirus disease 2019 (COVID
88 the detection of SARS-CoV-2, and tracing the asymptomatic carriers of COVID-19 rapidly and accurately
89 omatic carriers of emm4 and five (36%) of 14 asymptomatic carriers of emm3.93 had a positive cough pl
90  transmissibility was tested, one (9%) of 11 asymptomatic carriers of emm4 and five (36%) of 14 asymp
91 l, PLZF-expressing NK cells were retained in asymptomatic carriers of GATA2 mutation.
92                                 The study of asymptomatic carriers of GRN Thr272fs mutation (aGRN+) p
93 t herpetic disease from the vast majority of asymptomatic carriers of HSV-1 and HSV-2.
94 n individuals (24 healthy controls [HCs], 17 asymptomatic carriers of HTLV-1 (AC), 47 HAM/TSP, 74 rel
95                                           In asymptomatic carriers of HTLV-1 and in patients with HTL
96                                   If similar asymptomatic carriers of infection arise after exposure
97 ls will develop disease themselves or act as asymptomatic carriers of infectivity which might infect
98                                              Asymptomatic carriers of Plasmodium parasites hamper mal
99    As there are clinically reported cases of asymptomatic carriers of SARS-CoV-2, fast and accurate d
100                 Speech droplets generated by asymptomatic carriers of severe acute respiratory syndro
101                                 Thirty-three asymptomatic carriers of the disease gene were identifie
102 RNA copy numbers of the symptomatic with the asymptomatic carriers of the mutant PRPF31 allele.
103 ith Alzheimer's disease and most notably for asymptomatic carriers of the mutation than other traditi
104  new approach to determine the likelihood of asymptomatic carriers of the SARS-CoV-2 virus by using i
105 ory binding has been found to be affected in asymptomatic carriers of this mutation.
106 ctive cohort study in Denmark, we found that asymptomatic carriers of toxigenic C difficile in hospit
107 ectal swab specimens detected 17 (68%) of 25 asymptomatic carriers of toxigenic Clostridium difficile
108         Previous studies have suggested that asymptomatic carriers of toxigenic Clostridium difficile
109 surveillance testing to identify and isolate asymptomatic carriers of toxigenic Clostridium difficile
110                                 CDI rates in asymptomatic carriers of toxin-encoding strains were 5.3
111                                 CDI rates in asymptomatic carriers of toxin-encoding strains were 5.3
112 ifficile infection (CDI) were higher than in asymptomatic carriers of toxinogenic C. difficile.
113                             The prognosis of asymptomatic carriers of TTNtv is poorly understood beca
114 are consistent with the proposed key role of asymptomatic carriers of Typhi as the main reservoir of
115               We investigated the effects of asymptomatic carriers on nosocomial C difficile infectio
116 hematical model to investigate the effect of asymptomatic carriers on the long-term outcome of the di
117  105 HTLV-1+ T cell clones in the body of an asymptomatic carrier or patient with HTLV-1-associated m
118 ses may instead be due to transmissions from asymptomatic carriers or progression of latent C. diffic
119 in patients with untreated HAM compared with asymptomatic carriers (P < .001) but less so in those on
120  affected sibling or parent, and four had an asymptomatic carrier parent.
121   In both the affected individuals and their asymptomatic carrier parents, reduced SW-AF intensities,
122        Patients with Alzheimer's disease and asymptomatic carriers performed significantly worse than
123 nce, thereby potentially contributing to the asymptomatic carrier phenotype.
124                            We estimated that asymptomatic carriers play a crucial role in overall tra
125  of the causative gene has made detection of asymptomatic carriers possible, the extreme heterogeneit
126 l-world circumstances, such as the number of asymptomatic carriers present.
127                                           In asymptomatic carriers, qAF disclosed previously undetect
128                      All patients except one asymptomatic carrier showed pneumonia, including one wit
129 t in T-cell-dependent fatal meningitis or an asymptomatic carrier state amenable to immunotherapeutic
130 rgan transplant recipients often leads to an asymptomatic carrier state characterized by a persistent
131 NOD2, as well as the first observation of an asymptomatic carrier state for any of the NOD2 "Blau mut
132                  Salmonellae can exist in an asymptomatic carrier state in the human gallbladder.
133                The existence of a prolonged, asymptomatic carrier state is a political impediment for
134  known environmental reservoir, the chronic, asymptomatic carrier state is thought to be a key featur
135 e other patients with bacteriuria exhibit an asymptomatic carrier state similar to bacterial commensa
136 n colonize the gallbladder and persist in an asymptomatic carrier state that is frequently associated
137 ession that occurs upon establishment of the asymptomatic carrier state.
138 ve strain and the wild-type promoter into an asymptomatic carrier strain.
139                                              Asymptomatic carrier strains were shown to inhibit RNA p
140 lters the pathogen-host interaction of these asymptomatic carrier strains.
141             Comparison with evolution in two asymptomatic carriers supported the conclusion that clus
142 se viral markers were significantly lower in asymptomatic carriers than in HAM/TSP or ATL patients.
143 h lower parasitemia and tend to be higher in asymptomatic carriers than in patients.
144 usceptible, whereas others are resistant and asymptomatic carriers that can take part in disseminatin
145 e number of triplet repeats less than 60; in asymptomatic carriers the number of repeats is 60-200 (p
146                                Indeed, among asymptomatic carriers, the prevalence of NVTs has increa
147 control may be necessary, including tracking asymptomatic carriers through health-care systems.
148 ked transmission of multiple strains from an asymptomatic carrier to a patient diagnosed with primary
149 ential contribution of reservoirs, including asymptomatic carriers, to CA C. difficile transmission.
150                                  The role of asymptomatic carrier trees in the disease dynamics remai
151              Comparison of MRSA strains from asymptomatic carriers versus concurrently collected comm
152 l samples from 26 familial MDS/AML cases and asymptomatic carriers, we identified recurrent frameshif
153                                              Asymptomatic carriers were colonized with strains simila
154 0 (30.9%) of 194 meningococcal isolates from asymptomatic carriers were not groupable.
155 thod with age at onset as the time variable; asymptomatic carriers were right censored at the age at
156          Five subjects with HAM and 2 HTLV-1 asymptomatic carriers were studied.
157 x cyprinid and salmonid fishes, including an asymptomatic carrier, were selected as model hosts that
158 O1 strains are typified by a large number of asymptomatic carriers who excrete vibrios but do not dev
159 iae isolates, including 9 with infections, 7 asymptomatic carriers who had undergone ERCP, and 1 addi
160             We compared inflammation between asymptomatic carriers who remained clinically normal ('a
161                                Nineteen were asymptomatic carriers with low or high pVL; 19 were diag

 
Page Top